“…This includes evaluating potential harms, patient, and public acceptability of such tools, the implications of any such effort for health systems to address questions around who would be responsible for undertaking scoring and risk communication, and how model outcomes could inform “personalised medicine” plans [ 119 ]. Moreover, population-based strategies, in tandem with personalised medicine approaches, may provide a more holistic strategy to preventing dementia by not only having the potential to significantly reduce the overall prevalence of dementia but may also help address health disparities by ensuring that dementia prevention efforts are built in to society, and those that are individually orientated are appropriate and accessible [ 120 , 121 ]. Finally, there needs to be a consensus on the most well-developed models and focussing research resources on improving the clinical validity and utility of these models as a clinical risk prediction tool for application across diverse communities in the general population.…”